This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Emcure Pharmaceuticals Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Sougata Pramanick: Innovator in Pharmaceutical Composition
Introduction
Sougata Pramanick is a notable inventor based in Bhosari, India. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on carmustine compositions. His dedication to improving pharmaceutical solutions has led to the development of a unique product that enhances patient care.
Latest Patents
Sougata Pramanick holds a patent for a stable ready-to-use carmustine pharmaceutical composition. This invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution prior to addition to saline and dextrose parenteral solutions. The stable liquid pharmaceutical composition he developed simplifies the preparation process for healthcare providers, ensuring that patients receive effective treatment without unnecessary complications.
Career Highlights
Pramanick is currently employed at Emcure Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Emcure has allowed him to focus on innovative solutions that address critical healthcare needs. His contributions have been instrumental in advancing the company's product offerings and enhancing patient outcomes.
Collaborations
Throughout his career, Sougata has collaborated with talented professionals, including Aasiya Aslam Burhan and Mukund Keshav Gurjar. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical solutions.
Conclusion
Sougata Pramanick's work in developing a stable ready-to-use carmustine pharmaceutical composition exemplifies his commitment to innovation in the pharmaceutical field. His contributions not only benefit healthcare providers but also improve the quality of care for patients.
